K-numberK243097
Device nameRM STAR EX with RMS Needle
ApplicantBomtech Electronics Co., Ltd.
Product codeGEI
Device classClass II
Decision dateDec 26, 2024
DecisionSubstantially Equivalent
Regulation
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The RM STAR EX with RMS Needle is a bipolar radiofrequency electrosurgical device intended for use in dermatologic procedures to achieve electrocoagulation and hemostasis. It consists of a main body and handpiece that deliver RF energy at 2 MHz through penetrating needle electrodes in a consumable tip to create controlled heat within target skin tissue.

Technological characteristics

The device operates at a maximum output power of 16 W (50 Ω) at 2 MHz frequency with conduction times ranging from 100-200 msec (shorter than predicate's 120-300 msec). It achieves penetration depths of 0-2.0 mm (shallower than predicate's 0.3-4.0 mm) and uses 13-pin electrode configurations (fewer than predicate's 25-pin), all within a disposable consumable tip. Input voltage is AC 100-240 V, 50/60 Hz.

Test standards cited

ISO 10993 series (biocompatibility including cytotoxicity, sensitization, irritation, acute systemic toxicity, pyrogenicity); ISO 11135, 11138, 11737, 11140, and AAMI standards for sterilization validation; IEC 60601-1, IEC 60601-1-2, IEC 60601-2-2, EN 55011, and IEC 61000-3-2 for electrical safety and EMC; ASTM F88/F88M-15, F1929-15, D4169-22, and F1980-21 for packaging and shelf-life validation.

Substantial equivalence argument

The RM STAR EX is substantially equivalent to SYLFIRM X because both are bipolar RF electrosurgical coagulation devices with identical indications for use in dermatologic procedures, same operating frequency (2 MHz), same output power (16 W), same input voltage, and same prescription-use classification. Minor differences in conduction time, penetration depth, and electrode count do not raise safety concerns because the subject device's parameters are within acceptable ranges (shorter conduction times, shallower depths, fewer electrodes all represent conservative design choices), and safety and effectiveness were confirmed by animal testing showing controlled tissue interactions with good healing.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →